GB201505527D0 - Composition - Google Patents

Composition

Info

Publication number
GB201505527D0
GB201505527D0 GBGB1505527.0A GB201505527A GB201505527D0 GB 201505527 D0 GB201505527 D0 GB 201505527D0 GB 201505527 A GB201505527 A GB 201505527A GB 201505527 D0 GB201505527 D0 GB 201505527D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1505527.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JMEDTECH Pte Ltd
Original Assignee
JMEDTECH Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JMEDTECH Pte Ltd filed Critical JMEDTECH Pte Ltd
Priority to GBGB1505527.0A priority Critical patent/GB201505527D0/en
Publication of GB201505527D0 publication Critical patent/GB201505527D0/en
Priority to CN202110288835.1A priority patent/CN113181439A/zh
Priority to JP2017551593A priority patent/JP6824188B2/ja
Priority to PCT/SG2016/050158 priority patent/WO2016159885A1/en
Priority to EP19174733.6A priority patent/EP3586886B1/en
Priority to CN201680030900.8A priority patent/CN107921180A/zh
Priority to EP16773584.4A priority patent/EP3277330A4/en
Priority to US15/563,527 priority patent/US20180193537A1/en
Priority to EP22186638.7A priority patent/EP4129350B1/en
Priority to EP25190444.7A priority patent/EP4609886A3/en
Priority to US16/366,323 priority patent/US20190351108A1/en
Priority to JP2021002539A priority patent/JP7376520B2/ja
Priority to US17/305,851 priority patent/US11964076B2/en
Priority to JP2023181875A priority patent/JP7714014B2/ja
Priority to US18/609,954 priority patent/US12290616B2/en
Priority to US19/094,493 priority patent/US20250222180A1/en
Priority to JP2025118446A priority patent/JP2025160249A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/375—Constructional arrangements, e.g. casings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
GBGB1505527.0A 2015-03-31 2015-03-31 Composition Ceased GB201505527D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB1505527.0A GB201505527D0 (en) 2015-03-31 2015-03-31 Composition
JP2017551593A JP6824188B2 (ja) 2015-03-31 2016-03-31 弾性の抗菌フィルムおよびそれから作られるソケット
EP22186638.7A EP4129350B1 (en) 2015-03-31 2016-03-31 Elastic antimicrobial film and socket made therefrom
EP25190444.7A EP4609886A3 (en) 2015-03-31 2016-03-31 Elastic antimicrobial film and socket made therefrom
PCT/SG2016/050158 WO2016159885A1 (en) 2015-03-31 2016-03-31 Elastic antimicrobial film and socket made therefrom
EP19174733.6A EP3586886B1 (en) 2015-03-31 2016-03-31 Elastic antimicrobial film and socket made therefrom
CN201680030900.8A CN107921180A (zh) 2015-03-31 2016-03-31 弹性抗生素膜及由其制成的覆盖件的制备方法
EP16773584.4A EP3277330A4 (en) 2015-03-31 2016-03-31 Elastic antimicrobial film and socket made therefrom
US15/563,527 US20180193537A1 (en) 2015-03-31 2016-03-31 Elastic antimicrobial film and socket made therefrom
CN202110288835.1A CN113181439A (zh) 2015-03-31 2016-03-31 一种多层聚合物膜
US16/366,323 US20190351108A1 (en) 2015-03-31 2019-03-27 Multi-layered polymer film for sustained release of agents
JP2021002539A JP7376520B2 (ja) 2015-03-31 2021-01-12 弾性の抗菌フィルムおよびそれから作られるソケット
US17/305,851 US11964076B2 (en) 2015-03-31 2021-07-15 Multi-layered polymer film for sustained release of agents
JP2023181875A JP7714014B2 (ja) 2015-03-31 2023-10-23 弾性の抗菌フィルムおよびそれから作られるソケット
US18/609,954 US12290616B2 (en) 2015-03-31 2024-03-19 Multi-layered polymer film for sustained release of agents
US19/094,493 US20250222180A1 (en) 2015-03-31 2025-03-28 Multi-layered polymer film for sustained release of agents
JP2025118446A JP2025160249A (ja) 2015-03-31 2025-07-14 弾性の抗菌フィルムおよびそれから作られるソケット

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1505527.0A GB201505527D0 (en) 2015-03-31 2015-03-31 Composition

Publications (1)

Publication Number Publication Date
GB201505527D0 true GB201505527D0 (en) 2015-05-13

Family

ID=53178424

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1505527.0A Ceased GB201505527D0 (en) 2015-03-31 2015-03-31 Composition

Country Status (6)

Country Link
US (5) US20180193537A1 (https=)
EP (4) EP4609886A3 (https=)
JP (4) JP6824188B2 (https=)
CN (2) CN107921180A (https=)
GB (1) GB201505527D0 (https=)
WO (1) WO2016159885A1 (https=)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11202754B2 (en) 2017-10-06 2021-12-21 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
US11964076B2 (en) 2015-03-31 2024-04-23 Foundry Therapeutics, Inc. Multi-layered polymer film for sustained release of agents
US12303619B2 (en) 2018-08-28 2025-05-20 Foundry Therapeutics, Inc. Polymer implants
US12364792B2 (en) 2018-01-08 2025-07-22 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
US12458589B2 (en) 2018-05-12 2025-11-04 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018063096A1 (en) * 2016-09-28 2018-04-05 Orchid Medical Pte Ltd Elastic bioresorbable encasement for implants
EP3323435A1 (en) * 2016-11-17 2018-05-23 Heiko Sorg Active envelope silicone implant with drug space and multiphase mode of action for breast augmentation
CN107574581B (zh) * 2017-08-03 2019-09-10 天津大学 一种抗菌性聚(ε-己内酯)/模拟抗菌肽电纺纤维膜及其制备方法
US11458715B2 (en) 2018-11-07 2022-10-04 Industrial Technology Research Institute Bifunctional film and method for preparing the same
MX2021006372A (es) 2018-11-29 2021-08-11 Ethicon Inc Revestimientos lubricantes de silicona curada a baja temperatura.
DE102019213178A1 (de) * 2019-08-30 2021-03-04 Resorba Medical Gmbh Polymerfolie und Polymertasche zur Aufnahme eines zu implantierenden medizinisch-technischen Produkts
KR102352952B1 (ko) * 2021-03-29 2022-01-19 (주) 일론 유효 성분 시트를 선택적으로 고정하는 전극패드 프레임, 이를 포함하는 장치 및 이를 이용하는 유효 성분 시트
WO2022216259A1 (en) * 2021-04-09 2022-10-13 Bogazici Universitesi An envelope for implantable cardiac pacemakers
CN113398311B (zh) * 2021-05-25 2022-08-02 周建大 一种荷载纳米抗菌肽的多聚复合防护膜、制备方法及应用
EP4531999A1 (en) * 2022-05-31 2025-04-09 Medtronic, Inc. Cardiac monitor device
US20250195725A1 (en) * 2023-11-22 2025-06-19 Cook Biotech Incorporated Drug depot-bearing medical graft implants, and related methods and components

Family Cites Families (307)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4601893A (en) 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US4666704A (en) 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4919939A (en) 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
DE3734223A1 (de) 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem
JPH074418B2 (ja) 1988-10-28 1995-01-25 帝人株式会社 医療用繊維状物
US5227165A (en) 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
WO1992015286A1 (en) * 1991-02-27 1992-09-17 Nova Pharmaceutical Corporation Anti-infective and anti-inflammatory releasing systems for medical devices
AU3941493A (en) 1992-03-30 1993-11-08 Alza Corporation Viscous suspensions of controlled-release drug particles
US5458582A (en) 1992-06-15 1995-10-17 Nakao; Naomi L. Postoperative anesthetic delivery device and associated method for the postoperative treatment of pain
DK0659073T3 (da) 1992-09-10 2002-03-11 Childrens Medical Center Bionedbrydelige polymermatrixer med vedvarerende afgivelse af lokalanæstetika
US5700485A (en) 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5807306A (en) 1992-11-09 1998-09-15 Cortrak Medical, Inc. Polymer matrix drug delivery apparatus
AU5895994A (en) 1993-10-04 1995-05-01 Mark Chasin Controlled release microspheres
US5451408A (en) 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
NZ311474A (en) 1995-06-09 1997-09-22 Euro Celtique Sa Formulations for providing prolonged local anesthesia
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
DE19654884C2 (de) 1996-03-04 1999-07-29 Kirsch Axel Formkörper
GB9605915D0 (en) 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
US5747060A (en) 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5891506A (en) * 1996-08-09 1999-04-06 Medtronic, Inc. Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices
WO1997049391A1 (en) 1996-06-24 1997-12-31 Euro-Celtique, S.A. Methods for providing safe local anesthesia
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US5919473A (en) 1997-05-12 1999-07-06 Elkhoury; George F. Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
WO1998051290A2 (en) 1997-05-16 1998-11-19 Children's Medical Center Corporation Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
US6110902A (en) 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
US6248345B1 (en) 1997-07-02 2001-06-19 Euro-Celtique, S.A. Prolonged anesthesia in joints and body spaces
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US6306166B1 (en) 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
EP2198854B1 (en) 1997-09-18 2011-11-30 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
US6342250B1 (en) 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
KR100289471B1 (ko) 1998-01-19 2001-09-17 김충섭 휀타닐계마취제의이식형서방성제제
US6623521B2 (en) 1998-02-17 2003-09-23 Md3, Inc. Expandable stent with sliding and locking radial elements
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6451335B1 (en) 1998-07-02 2002-09-17 Euro-Celtique S.A. Formulations and methods for providing prolonged local anesthesia
KR20010112285A (ko) 1999-02-23 2001-12-20 추후보충 손상된 신체 통로와 공동의 집결성을 향상시키기 위한조성물 및 방법
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US9302903B2 (en) 2000-12-14 2016-04-05 Georgia Tech Research Corporation Microneedle devices and production thereof
US20030152637A1 (en) 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
WO2002089849A1 (en) 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
KR20040014544A (ko) 2001-06-05 2004-02-14 컨트롤 딜리버리 시스템즈 인코포레이티드 서방 진통제 화합물
US6913760B2 (en) 2001-08-06 2005-07-05 New England Medical Hospitals, Inc. Drug delivery composition
US6913626B2 (en) 2001-08-14 2005-07-05 Mcghan Jim J. Medical implant having bioabsorbable textured surface
AU2002341959A1 (en) 2001-10-04 2003-04-14 Case Western Reserve University Drug delivery devices and methods
US20030074055A1 (en) 2001-10-17 2003-04-17 Haverkost Patrick A. Method and system for fixation of endoluminal devices
US20030157162A1 (en) 2002-01-22 2003-08-21 Krugner-Higby Lisa A. Liposome-encapsulated opioid analgesics
US7993390B2 (en) * 2002-02-08 2011-08-09 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US7074426B2 (en) 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
US7264822B2 (en) 2002-04-03 2007-09-04 Poly-Med, Inc. Conjugated drug-polymer coated stent
AU2003241515A1 (en) * 2002-05-20 2003-12-12 Orbus Medical Technologies Inc. Drug eluting implantable medical device
US20050266077A1 (en) 2002-06-20 2005-12-01 Royal Biomedical, Inc. Resorbable matrices with coatings for delivery of bioactive compounds
US20040109893A1 (en) 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
CN1267084C (zh) * 2002-08-01 2006-08-02 复旦大学 可控制药物释放的植入式医疗器械制备方法
US20050019404A1 (en) 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
US20120097194A1 (en) * 2002-09-09 2012-04-26 Reactive Surfaces, Ltd. Polymeric Coatings Incorporating Bioactive Enzymes for Catalytic Function
FR2846557B1 (fr) 2002-10-30 2007-06-08 Statice Sante Structure implantable pour la liberation prolongee et controlee d'un principe actif
US20040156931A1 (en) 2002-12-18 2004-08-12 Algorx Administration of capsaicinoids
EP1608359A4 (en) 2003-04-03 2011-08-17 Jessie L-S Au DRUG-LOADING PARTICLES TARGETING TUMORS
US7220433B2 (en) 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
US20070134292A1 (en) 2003-07-17 2007-06-14 Esa Suokas Synthetic, bioabsorbable polymer materials and implants
US20050043786A1 (en) 2003-08-18 2005-02-24 Medtronic Ave, Inc. Methods and apparatus for treatment of aneurysmal tissue
US20050048115A1 (en) 2003-08-27 2005-03-03 Murty Mangena Buprenorphine microspheres
NZ546182A (en) 2003-09-26 2009-08-28 Alza Corp Controlled release formulations of opioid and nonopioid analgesics such as hydrocodone and acetaminophen
US8257393B2 (en) 2003-12-04 2012-09-04 Ethicon, Inc. Active suture for the delivery of therapeutic fluids
US7557051B2 (en) 2004-03-17 2009-07-07 The Board Of Trustees Of The Leland Stanford Junior University 3-D interconnected multi-layer microstructure of thermoplastic materials
US20070258939A1 (en) 2004-08-03 2007-11-08 Biocamparibles Uk Limited Drug Delivery from Embolic Agents
US20080311191A1 (en) 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
WO2006026412A2 (en) 2004-08-31 2006-03-09 Vnus Medical Technologies, Inc. Apparatus and material composition for permanent occlusion of a hollow anatomical structure
US8603528B2 (en) 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
SI2415484T1 (sl) 2004-09-17 2014-10-30 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
AU2012201226B2 (en) 2004-09-17 2014-08-14 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
US8750983B2 (en) 2004-09-20 2014-06-10 P Tech, Llc Therapeutic system
US20060079558A1 (en) 2004-09-27 2006-04-13 Bridge Pharma. Inc. R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
WO2006036936A2 (en) 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US20060253100A1 (en) 2004-10-22 2006-11-09 Medtronic, Inc. Systems and Methods to Treat Pain Locally
US8067026B2 (en) 2005-03-14 2011-11-29 Boston Scientific Scimed, Inc. Drug release regions for medical devices, which include polycyclic-structure-containing polymers
US20090087380A1 (en) 2005-04-11 2009-04-02 Fasching Rainer J Polymer devices for therapeutic applications
EP1872390A2 (en) 2005-04-11 2008-01-02 The Board of Trustees of the Leland Stanford Junior University Multi-layer structure having a predetermined layer pattern including an agent
MX2007013213A (es) 2005-04-25 2007-12-12 Amgen Inc Composiciones de liberacion prolongada de peptidos biodegradables que contienen porogenos.
EP1901733B1 (en) 2005-05-23 2016-04-06 President and Fellows of Harvard College Huperzine for use in the treatment of neuropathic pain
US8865205B2 (en) 2005-06-15 2014-10-21 Poly-Med, Inc. Bioswellable sutures
EP1898955A2 (en) 2005-06-17 2008-03-19 Nektar Therapeutics AL, Corporation Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs
US9763788B2 (en) * 2005-09-09 2017-09-19 Board Of Trustees Of The University Of Arkansas Bone regeneration using biodegradable polymeric nanocomposite materials and applications of the same
CA2623239C (en) 2005-09-22 2016-07-12 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
MX2008004094A (es) 2005-09-27 2009-02-27 Efrat Biopolymers Ltd Composiciones de polimero inyectables hidrofobicas, gelificantes.
WO2007038625A2 (en) 2005-09-28 2007-04-05 Northwestern University Biodegradable nanocomposites with enhanced mechanical properties for soft tissue engineering.
CN1762331A (zh) 2005-10-13 2006-04-26 上海交通大学 骨架型药膜包裹的消化道支架
CN103251449B (zh) 2005-10-13 2016-03-02 斯恩蒂斯有限公司 载药包装物
US20070141106A1 (en) 2005-10-19 2007-06-21 Bonutti Peter M Drug eluting implant
US20070173787A1 (en) 2005-11-01 2007-07-26 Huang Mark C T Thin-film nitinol based drug eluting stent
ATE499076T1 (de) 2006-01-13 2011-03-15 Barry M Fell Chirurgisch implantierbare prothese mit einer aktiven komponente
US20070178138A1 (en) 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
US7824703B2 (en) 2006-02-01 2010-11-02 Warsaw Orthopedics, Inc. Medical implants with reservoir(s), and materials preparable from same
EP2114298B1 (en) 2006-02-08 2022-10-19 Medtronic, Inc. Temporarily stiffened mesh prostheses
US8315700B2 (en) * 2006-02-08 2012-11-20 Tyrx, Inc. Preventing biofilm formation on implantable medical devices
US8591531B2 (en) * 2006-02-08 2013-11-26 Tyrx, Inc. Mesh pouches for implantable medical devices
EP2004172B1 (en) 2006-03-31 2019-03-13 Mati Therapeutics Inc. Drug delivery structures and compositions for nasolacrimal system
US7741273B2 (en) 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
US9173732B2 (en) 2006-04-25 2015-11-03 The Children's Medical Center Corporation Medical devices for use in the surgical treatment of hyperproliferative diseases affecting the spinal cord
US7833270B2 (en) 2006-05-05 2010-11-16 Warsaw Orthopedic, Inc Implant depots to deliver growth factors to treat osteoporotic bone
US20080124372A1 (en) 2006-06-06 2008-05-29 Hossainy Syed F A Morphology profiles for control of agent release rates from polymer matrices
US7723291B2 (en) 2006-07-27 2010-05-25 Warsaw Orthopedic, Inc. Release of BMP, bioactive agents and/or cells via a pump into a carrier matrix
WO2008060359A2 (en) 2006-09-29 2008-05-22 Surmodics, Inc. Biodegradable ocular implants and methods for treating ocular conditions
CN101161299B (zh) * 2006-10-09 2011-07-06 乐普（北京）医疗器械股份有限公司 孔洞及聚合物共载的药物释放结构及其制备方法
US8039010B2 (en) 2006-11-03 2011-10-18 Allergan, Inc. Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
AU2013200515C1 (en) 2006-11-06 2016-09-22 Medtronic, Inc. Mesh pouches for implantable medical devices
MX2009004819A (es) 2006-11-06 2009-11-23 Tyrx Pharma Inc Bolsas reabsorbibles para dispositivos medicos implantables.
US9023114B2 (en) 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
MX2009004821A (es) 2006-11-06 2009-11-23 Tyrx Pharma Inc Bolsas de malla para dispositivos medicos implantables.
WO2008061355A1 (en) 2006-11-24 2008-05-29 Matregen Corp. Glp-1 depot systems, and methods of manufacture and uses thereof
US20080154241A1 (en) 2006-12-07 2008-06-26 Burkstrand Michael J Latent stabilization of bioactive agents releasable from implantable medical articles
WO2008112592A1 (en) 2007-03-09 2008-09-18 Anthem Orthopaedics Llc Implantable medicament delivery device and delivery tool and method for use therewith
AU2008232682B2 (en) * 2007-03-29 2013-03-21 Medtronic, Inc. Biodegradable, polymer coverings for breast implants
ATE551077T1 (de) 2007-04-17 2012-04-15 Medtronic Inc Minderung einer infektion in zusammenhang mit einer medizinischen vorrichtung
US8430852B2 (en) 2007-04-17 2013-04-30 Medtronic, Inc. Therapeutic sleeve for implantable medical device
WO2008151040A2 (en) 2007-05-31 2008-12-11 Cook Biotech Incorporated Analgesic coated medical product
EP2173412A4 (en) 2007-07-06 2011-07-27 Allievion Medical Inc LIQUID LIQUIDING DEVICE
US20110281882A1 (en) 2007-08-10 2011-11-17 Jinzhong Zhang Compositions and Methods for Treating, Controlling, Reducing, or Ameliorating Inflammatory Pain
US20110137243A1 (en) * 2007-09-06 2011-06-09 Abbott Cardiovascular Systems Inc. Coating On A Balloon Device
US9248219B2 (en) 2007-09-14 2016-02-02 Boston Scientific Scimed, Inc. Medical devices having bioerodable layers for the release of therapeutic agents
US8470360B2 (en) 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
WO2009046299A2 (en) 2007-10-04 2009-04-09 Boston Scientific Scimed, Inc Implantable drug depot for intrathecal drug delivery system for pain management
WO2009044403A2 (en) 2007-10-05 2009-04-09 Juvenis Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
JP2011500150A (ja) * 2007-10-10 2011-01-06 エムアイヴィ テラピューティクス， インコーポレイテッド インプラント用医療デバイスのための脂質コーティング
US8974814B2 (en) * 2007-11-12 2015-03-10 California Institute Of Technology Layered drug delivery polymer monofilament fibers
EP2222284B1 (en) 2007-11-19 2020-07-01 Capsulated Systems Inc. Prolonged release of local anesthetics using microparticles and surgery applications
US8221358B2 (en) 2007-11-20 2012-07-17 Warsaw Orthopedic, Inc. Devices and methods for delivering drug depots to a site beneath the skin
WO2009069151A2 (en) 2007-11-30 2009-06-04 Matrix Laboratories Limited Controlled release composition
EP2067494A1 (en) 2007-12-04 2009-06-10 Charité-Universitätsmedizin Berlin Sheet or tubular structure consisting of elastic biocompatible material and its use
US8523569B2 (en) 2007-12-28 2013-09-03 Khashayar Kevin Neshat Controlled release local anesthetic for post dental surgery and method of use
WO2009088726A2 (en) 2007-12-31 2009-07-16 Acclarent, Inc. Mucosal tissue dressing and method of use
US20090177229A1 (en) 2008-01-03 2009-07-09 New York Society Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery Suture anchor with drug/growth factor delivery reservoir
ES2603961T3 (es) 2008-02-29 2017-03-02 Smith & Nephew, Inc. Recubrimiento de gradiente para aplicaciones biomédicas
US9289409B2 (en) 2008-04-18 2016-03-22 Warsaw Orthopedic, Inc. Sulindac formulations in a biodegradable material
US8629172B2 (en) 2008-04-18 2014-01-14 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising clonidine
US8946277B2 (en) 2008-04-18 2015-02-03 Warsaw Orthopedic, Inc. Clonidine formulations in a biodegradable polymer carrier
US8420114B2 (en) 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
US20090264477A1 (en) 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc., An Indiana Corporation Beta adrenergic receptor agonists for treatment of pain and/or inflammation
US9072727B2 (en) 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US9132085B2 (en) 2008-04-18 2015-09-15 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using clonidine and bupivacaine
US20090263451A1 (en) 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
US8846068B2 (en) 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US8524267B2 (en) 2008-04-18 2013-09-03 Warsaw Orthopedic, Inc. Dexamethasone formulations in a biodegradable material
US9610243B2 (en) 2008-04-18 2017-04-04 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20090264489A1 (en) 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
US9125917B2 (en) 2008-04-18 2015-09-08 Warsaw Orthopedic, Inc. Fluocinolone formulations in a biodegradable polymer carrier
US8889173B2 (en) 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8557273B2 (en) 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
US8956641B2 (en) 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US20090263443A1 (en) 2008-04-18 2009-10-22 Warsaw Orthopedics, Inc. Methods for treating post-operative effects such as spasticity and shivering with clondine
US9132119B2 (en) 2008-04-18 2015-09-15 Medtronic, Inc. Clonidine formulation in a polyorthoester carrier
KR20130097813A (ko) 2008-04-21 2013-09-03 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
WO2009132153A2 (en) 2008-04-22 2009-10-29 Angiotech Pharmaceuticals, Inc. Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same
WO2009134371A2 (en) 2008-04-30 2009-11-05 Qlt Plug Delivery, Inc. Composite lacrimal insert and related methods
CN102112107A (zh) 2008-06-03 2011-06-29 托马医疗科技公司 具有改进的释放动力学特征的控制释放共聚物制剂
US8652525B2 (en) 2008-07-10 2014-02-18 Tyrx, Inc. NSAID delivery from polyarylates
EP2313122B1 (en) * 2008-07-17 2019-03-06 Micell Technologies, Inc. Drug delivery medical device
US8202531B2 (en) 2008-07-23 2012-06-19 Warsaw Orthopedic, Inc. Drug depots having one or more anchoring members
ES2356883B1 (es) 2008-07-24 2012-02-22 Bcn Peptides, S.A. Composición para el tratamiento del dolor y/o la inflamación.
US9808345B2 (en) 2008-07-24 2017-11-07 Iorthopedics, Inc. Resilient arthroplasty device
JP2011530322A (ja) 2008-08-05 2011-12-22 チルドレンズ メディカル センター コーポレイション 脊髄に影響を及ぼす過剰増殖性疾患の外科的治療において使用するための医療デバイス
AU2009285774B2 (en) 2008-08-28 2014-06-12 Kpr U.S., Llc Anti-microbial fibers and related articles and methods
US20110224245A1 (en) 2008-09-04 2011-09-15 President And Fellows Of Harvard College Treatment Of Neurological Disorders Using Huperzine
US9352137B2 (en) 2008-10-29 2016-05-31 Warsaw Orthopedic, Inc. Drug cartridge for delivering a drug depot comprising a bulking agent and/or cover
US9623222B2 (en) 2008-10-30 2017-04-18 Warsaw Orthopedic, Inc. Drug depot with anchor
US9161903B2 (en) 2008-10-31 2015-10-20 Warsaw Orthopedic, Inc. Flowable composition that hardens on delivery to a target tissue site beneath the skin
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
CA2746220A1 (en) 2008-12-08 2010-07-08 Vm Pharma Llc Compositions of protein receptor tyrosine kinase inhibitors
US8980317B2 (en) 2008-12-23 2015-03-17 Warsaw Orthopedic, Inc. Methods and compositions for treating infections comprising a local anesthetic
US9480643B2 (en) 2008-12-23 2016-11-01 Surmodics Pharmaceuticals, Inc. Implantable composites and implants comprising same
WO2010075298A2 (en) 2008-12-23 2010-07-01 Surmodics Pharmaceuticals, Inc. Implantable composites and compositions comprising releasable bioactive agents
US20100198278A1 (en) 2009-02-02 2010-08-05 Medtronic, Inc. Composite antimicrobial accessory including a membrane layer and a porous layer
US20100203102A1 (en) 2009-02-10 2010-08-12 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using bupivacaine and an anti-onflammatory agent
US8734829B2 (en) 2009-02-13 2014-05-27 Boston Scientific Scimed, Inc. Medical devices having polymeric nanoporous coatings for controlled therapeutic agent delivery and a nonpolymeric macroporous protective layer
WO2010101901A2 (en) 2009-03-02 2010-09-10 Boston Scientific Scimed, Inc. Self-buffering medical implants
US20100230100A1 (en) * 2009-03-13 2010-09-16 Reservoir Management Inc. Plug for a Perforated Liner and Method of Using Same
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
US20100249783A1 (en) 2009-03-24 2010-09-30 Warsaw Orthopedic, Inc. Drug-eluting implant cover
EP2424448A4 (en) 2009-04-27 2015-03-04 Intersect Ent Inc DEVICES AND METHODS FOR TREATING A PAIN ASSOCIATED WITH AMYGDALECTOMIES
WO2015073571A1 (en) 2013-11-15 2015-05-21 Dose Medical Corporation Ocular implants configured to store and release stable drug formulations
US8992601B2 (en) * 2009-05-20 2015-03-31 480 Biomedical, Inc. Medical implants
AU2010267528A1 (en) * 2009-07-01 2012-02-02 Dexcel Pharma Technologies Ltd. Local therapeutic release device
US8715223B2 (en) 2009-07-22 2014-05-06 Warsaw Orthopedic, Inc. Device and method for delivery of a drug depot near the nerve
US20110027331A1 (en) 2009-07-29 2011-02-03 Warsaw Orthopedic, Inc. An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
US8231891B2 (en) 2009-07-31 2012-07-31 Warsaw Orthopedic, Inc. Implantable drug depot for weight control
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
US20110086083A1 (en) * 2009-09-22 2011-04-14 Danielle Biggs Implant devices for modulating bioactive agent release profiles
US20110082545A1 (en) 2009-10-01 2011-04-07 Lipose Corporation Drug eluting breast implant cover or coating
US20110097375A1 (en) 2009-10-26 2011-04-28 Warsaw Orthopedic, Inc. Formulation for preventing or reducing bleeding at a surgical site
US20110129801A1 (en) 2009-11-27 2011-06-02 Shikha Pramanik Barman Compositions and methods to prevent and treat dry socket post-operatively after tooth extraction surgery
US8383161B2 (en) 2009-12-15 2013-02-26 Incept, Llc Radioopaque covalently crosslinked hydrogel particle implants
PL3884988T3 (pl) 2009-12-17 2025-09-08 Taris Biomedical Llc Urządzenie implantowalne z tolerancją wewnątrzpęcherzową
US9668948B2 (en) 2009-12-23 2017-06-06 Shannon Elizabeth Klingman Products and methods for reducing malodor from the pudendum
US20110159072A1 (en) * 2009-12-30 2011-06-30 Surmodics, Inc. Controlled release matrix
ES2732150T3 (es) 2010-01-20 2019-11-20 Urogen Pharma Ltd Material y método para tratar cavidades internas
US9125902B2 (en) 2010-01-28 2015-09-08 Warsaw Orthopedic, Inc. Methods for treating an intervertebral disc using local analgesics
US8951552B2 (en) 2010-02-02 2015-02-10 Poly-Med, Inc. In situ film-forming bioactive solutions of absorbable multiblock copolymers
WO2011098578A2 (en) 2010-02-12 2011-08-18 Bioneer A/S Liposome system for ocular administration
US8758798B2 (en) 2010-03-24 2014-06-24 Covidien Lp Therapeutic implant
WO2011139594A2 (en) 2010-04-27 2011-11-10 Medtronic, Inc. Artificial bursa for intra-articular drug delivery
US20130136811A1 (en) 2010-05-26 2013-05-30 President And Fellows Of Harvard College Compositions and Methods for Pain Reduction
US20120009240A1 (en) 2010-07-08 2012-01-12 Joshua Stopek Films for Delivery of a Therapeutic Agent
IT1401498B1 (it) 2010-07-30 2013-07-26 Mero Srl Idrogelo a base di acido ialuronico e suo uso in ortopedia
US8697117B2 (en) 2010-08-02 2014-04-15 Ramot At Tel-Aviv University Ltd. Drug-eluting films
US8246571B2 (en) 2010-08-24 2012-08-21 Warsaw Orthopedic, Inc. Drug storage and delivery device having a retaining member
US9457176B2 (en) 2010-10-06 2016-10-04 Taris Biomedical Llc Implantable drug delivery device with bladder retention feature
US8920867B2 (en) 2010-10-19 2014-12-30 Covidien Lp Methods of forming self-supporting films for delivery of therapeutic agents
US8632839B2 (en) 2010-10-19 2014-01-21 Covidien Lp Methods of forming self-supporting films for delivery of therapeutic agents
US9861590B2 (en) 2010-10-19 2018-01-09 Covidien Lp Self-supporting films for delivery of therapeutic agents
EP2632553B1 (en) 2010-10-28 2020-01-01 Pacira Pharmaceuticals, Inc. A sustained release formulation of a non-steroidal anti-inflammatory drug
CN102389616A (zh) * 2010-11-02 2012-03-28 东南大学 纳米银聚合物蜂巢结构覆膜抗菌医用导管
AU2011326417A1 (en) * 2010-11-12 2013-05-09 Tyrx, Inc. Anchorage devices comprising an active pharmaceutical ingredient
WO2012075447A2 (en) 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
CN102000366A (zh) 2010-12-08 2011-04-06 苏州同科生物材料有限公司 一种可降解自膨胀食管支架及其制备方法
EP2654757A1 (en) 2010-12-22 2013-10-30 Entarco SA The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
CA2827330A1 (en) 2011-02-23 2012-08-30 Ams Research Corporation Pelvic implant and therapeutic agent system and method
US9351924B2 (en) 2011-03-11 2016-05-31 Snu R&Db Foundation Drug delivery system including laminated structure
US9005634B2 (en) 2011-04-13 2015-04-14 Medtronic, Inc. Shelf stable pharmaceutical depot
CN103547255B (zh) 2011-04-14 2018-07-06 加利福尼亚大学董事会 多层薄膜药物递送装置以及其制造和使用方法
JP5727292B2 (ja) 2011-05-11 2015-06-03 富士フイルム株式会社 複合フィルム
KR101248368B1 (ko) 2011-05-24 2013-04-01 서울대학교산학협력단 약물이 탑재된 고분자 필름을 포함하는 봉합사 및 이의 제조방법
US10464100B2 (en) 2011-05-31 2019-11-05 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
WO2012170655A1 (en) 2011-06-07 2012-12-13 Cornell University Silk compositions and methods of using same
US20120316199A1 (en) 2011-06-07 2012-12-13 Ward Keith W Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
EP2718374A4 (en) 2011-06-09 2015-03-04 Agency Science Tech & Res CORE CASE MICRO BALLS
US9132194B2 (en) 2011-07-12 2015-09-15 Warsaw Orthopedic, Inc. Medical devices and methods comprising an adhesive sheet containing a drug depot
AU2012283875B2 (en) 2011-07-20 2016-05-12 Medtronic, Inc. Drug eluting mesh to prevent infection of indwelling transdermal devices
WO2013040325A1 (en) 2011-09-15 2013-03-21 Arsenal Medical, Inc. Implants for post-operative pain
US20150038415A1 (en) 2011-12-16 2015-02-05 Dsm Ip Assets B.V. Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent
EP2793968A1 (en) * 2011-12-22 2014-10-29 Janssen Biotech, Inc. Multilayer polymeric drug delivery system
US9198758B2 (en) 2012-01-26 2015-12-01 Warsaw Orthopedic, Inc. Delivery systems
WO2013124867A1 (en) 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules
WO2013126552A1 (en) 2012-02-21 2013-08-29 Auburn University Buprenorphine nanoparticle composition and methods thereof
US20130261594A1 (en) 2012-03-30 2013-10-03 Covidien Lp Implantable Devices Including A Mesh And An Extendable Film
EP2846773A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A LOCAL ANESTHETICS AND METHOD FOR THE MANUFACTURE THEREOF
US9655994B2 (en) 2012-07-25 2017-05-23 William F. McKay Delivery systems
EP3791861A1 (en) 2012-07-26 2021-03-17 Camurus AB Opioid formulations
NZ704012A (en) 2012-07-26 2017-09-29 Camurus Ab Opioid formulations
US20140052183A1 (en) 2012-08-10 2014-02-20 FreeseTEC Corporation Posterior Spine Attachment Device for Hardware and Paraspinal Musculature
GR20120100450A (el) 2012-08-30 2014-03-17 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης-Ειδικος Λογαριασμος Κονδυλιων Ερευνας, Μεθοδος παρασκευης πολυστρωματικων, βιοαποικοδομησιμων πολυμερικων επικαλυψεων με νανοπορους και τα προϊοντα της
US9198999B2 (en) 2012-09-21 2015-12-01 Merit Medical Systems, Inc. Drug-eluting rotational spun coatings and methods of use
JPWO2014046191A1 (ja) 2012-09-21 2016-08-18 テルモ株式会社 局所麻酔薬持続徐放性リポソーム製剤
US20140105956A1 (en) 2012-10-11 2014-04-17 Rupak BANERJEE Biodegradable polymer based microimplant for ocular drug delivery
US20140107159A1 (en) 2012-10-12 2014-04-17 Covidien Lp Compositions and methods of forming films for improved drug delivery
JP2015534952A (ja) 2012-10-19 2015-12-07 胡幼圃 効果の長い鎮痛薬・セバシン酸ジナルブフィンのｐｌｇａ徐放性剤
CA2888840C (en) * 2012-10-23 2021-06-22 Dsm Ip Assets B.V. Process for the manufacturing of a multilayer drug delivery construct
US20150290170A1 (en) 2012-10-26 2015-10-15 Allergan, Inc. Ketorolac-containing sustained release drug delivery systems
WO2014066653A1 (en) 2012-10-26 2014-05-01 Allergan, Inc. Ketorolac-containing sustained release intraocular drug delivery systems
US20150272877A1 (en) 2012-10-26 2015-10-01 Allergan, Inc. Ketorolac-containing sustained release drug delivery systems
BR112015009839A2 (pt) 2012-11-01 2017-07-11 Torrent Pharmaceuticals Ltd composição farmacêutica de tapentadol para administração parenteral
US9545447B2 (en) 2013-01-04 2017-01-17 The Texas A&M University System Polymer-drug systems
US9597132B2 (en) 2013-01-12 2017-03-21 Louis Houff Sternum fixation device and method
WO2014120587A1 (en) 2013-01-30 2014-08-07 Boston Scientific Scimed, Inc. Ureteral stent with drug-releasing structure
WO2014137454A1 (en) * 2013-03-07 2014-09-12 Tyrx, Inc. Methods and compositions to inhibit the assemblage of microbial cells irreversibly associated with surfaces of medical devices
CN105358129A (zh) 2013-03-15 2016-02-24 赫伦治疗有限公司 聚原酸酯和质子惰性溶剂的组合物
US20140271770A1 (en) 2013-03-15 2014-09-18 Warsaw Orthopedic, Inc. Methods And Compositions For Treating Post-Operative Pain Comprising Clonidine
SG10201604814WA (en) 2013-03-21 2016-08-30 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
US9849217B2 (en) * 2013-04-18 2017-12-26 Board Of Regents, The University Of Texas System Antimicrobial wraps for medical implants
CN103405748B (zh) 2013-05-24 2015-09-30 浙江圣兆药物科技股份有限公司 全新的双层聚合物包裹的多肽缓释释放组合物
CN105555328B (zh) 2013-06-21 2019-01-11 德普伊新特斯产品公司 膜及制造方法
US20150024031A1 (en) 2013-07-17 2015-01-22 Baxter International Inc. Methods And Compositions For Reducing Pain, Inflammation, And/Or Immunological Reactions Associated With Parenterally Administering A Primary Therapeutic Agent
IN2013MU02532A (https=) * 2013-07-31 2015-06-26 Sahajanand Medical Technologies Pvt Ltd
US20160331853A1 (en) 2014-01-21 2016-11-17 The Trustees Of Columbia University In The City Of New York Compositions for radiotherapy and uses thereof
AU2015228989B2 (en) 2014-03-11 2019-08-29 Atro Medical B.V. Meniscus prosthesis
CA2946281C (en) 2014-04-21 2022-12-13 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
US20150342964A1 (en) 2014-05-30 2015-12-03 Warsaw Orthopedic, Inc. Dexamethasone polymer implant for pain
CA2990825A1 (en) 2014-06-25 2015-12-30 William L. Hunter Devices, systems and methods for using and monitoring orthopedic hardware
EP3160369A4 (en) 2014-06-25 2018-04-18 Canary Medical Inc. Devices, systems and methods for using and monitoring spinal implants
US20160038632A1 (en) 2014-08-07 2016-02-11 Massachusetts Instutite Of Technology Adaptive Drug Delivery from an Artificial Polymer Skin with Tunable Properties for Tissue Engineering
EP3193847A4 (en) 2014-09-19 2018-06-06 Eupraxia Pharmaceuticals Inc. Injectable microparticles for hyper-localized release of therapeutic agents
US10449152B2 (en) 2014-09-26 2019-10-22 Covidien Lp Drug loaded microspheres for post-operative chronic pain
CN104474595B (zh) 2014-11-13 2017-01-25 中国科学院化学研究所 具有辅助治疗食管癌功能的双层复合覆膜的食管支架的制备方法
US20160136094A1 (en) 2014-11-18 2016-05-19 PixarBio Corporation Compositions For Treating Acute, Post-Operative, or Chronic Pain and Methods of Using the Same
CN104623681A (zh) 2014-11-26 2015-05-20 嘉应学院医学院 一种基于齐墩果酸的药物缓释剂及其制备方法
CN107427584A (zh) 2015-01-28 2017-12-01 阿勒根公司 关节脂肪垫制剂及其使用方法
US20160220498A1 (en) 2015-01-29 2016-08-04 Aneesh SONI Fully or partially biodegradable device for controlled drug delivery
US20160287367A1 (en) 2015-03-30 2016-10-06 Daniel A. Rontal Bioresorbable septoplasty closure implant
GB201505527D0 (en) * 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
CZ307444B6 (cs) 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
AU2016298210B2 (en) 2015-07-28 2021-12-09 Board Of Regents, The University Of Texas System Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
KR20170025011A (ko) 2015-08-27 2017-03-08 고려대학교 산학협력단 통증완화약물의 지속성 방출을 위한 약학적 조성물 및 그 투여를 위한 투여 장치
MX2018005035A (es) 2015-10-27 2018-09-06 Eupraxia Pharmaceuticals Inc Formulaciones de liberacion sostenida de anestesicos locales.
US20170128632A1 (en) 2015-11-10 2017-05-11 II William Charles McJames Device and method for controlling the release of bioactive and therapeutic agents from an implantable medical device
US10315034B2 (en) 2016-02-02 2019-06-11 Pacesetter, Inc. Systems and methods for reducing pain during spinal cord stimulation trial
EP3419679A1 (en) 2016-02-22 2019-01-02 The Methodist Hospital Implantable drug delivery systems
US20170239183A1 (en) 2016-02-23 2017-08-24 PixarBio Corporation COMPOSITIONS COMPRISING NAv1.7 SELECTIVE INHIBITORS FOR TREATING ACUTE, POST-OPERATIVE, OR CHRONIC PAIN AND METHODS OF USING THE SAME
BR112018075986B1 (pt) 2016-07-06 2022-11-16 Rhode Island Hospital Dispositivo para reparação de ligamento ou tendão
WO2018063096A1 (en) 2016-09-28 2018-04-05 Orchid Medical Pte Ltd Elastic bioresorbable encasement for implants
US11471419B2 (en) 2016-09-30 2022-10-18 The Board Of Trustees Of The University Of Illinois Capsules with intracapsular microspheres for improved survival and function of encapsulated cells
CN106344521B (zh) 2016-09-30 2019-10-25 沈阳药科大学 一种高载药量可生物降解布比卡因微球的制备及其应用
EP3522825B1 (en) 2016-10-05 2023-06-07 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
DE102017106216A1 (de) 2017-03-22 2018-09-27 Amw Gmbh Extrudierte Depotform zur anhaltenden Wirkstofffreisetzung
WO2018227293A1 (en) 2017-06-13 2018-12-20 The University Of British Columbia Polymeric paste compositions for drug delivery
WO2019071245A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. IMPLANTABLE DEPOSITS FOR REGULATED RELEASE OF ANALGESICS TO TREAT POSTHOPERATIVE PAIN ASSOCIATED WITH ORTHOPEDIC SURGERY, AND RELATED DEVICES, SYSTEMS, AND METHODS
WO2019136490A1 (en) 2018-01-08 2019-07-11 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
EP3793536A1 (en) 2018-05-12 2021-03-24 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents
US12303619B2 (en) 2018-08-28 2025-05-20 Foundry Therapeutics, Inc. Polymer implants
WO2020046973A1 (en) 2018-08-28 2020-03-05 Foundry Therapeutics 1, Inc. Devices, systems, and methods for delivering, positioning, and securing polymer depots in situ
US20220183964A1 (en) 2019-04-11 2022-06-16 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled, sustained release of therapeutic agents
CA3135760A1 (en) 2019-04-11 2020-10-15 Foundry Therapeutics, Inc. Implantable depots for localized, sustained, controlled release of therapeutic agents to treat cancer and related symptoms and conditions
WO2021178930A1 (en) 2020-03-05 2021-09-10 Foundry Therapeutics, Inc. Polymer implants
US20240016774A1 (en) 2020-10-14 2024-01-18 Foundry Therapeutics, Inc. Implantable depots for localized, sustained, controlled release of therapeutic agents to treat cancer and related conditions
CA3233429A1 (en) 2021-09-30 2023-04-06 Foundry Therapeutics, Inc. Implantable depots with tunable release profiles

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11964076B2 (en) 2015-03-31 2024-04-23 Foundry Therapeutics, Inc. Multi-layered polymer film for sustained release of agents
US12290616B2 (en) 2015-03-31 2025-05-06 Foundry Therapeutics, Inc. Multi-layered polymer film for sustained release of agents
US11202754B2 (en) 2017-10-06 2021-12-21 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
US11224570B2 (en) 2017-10-06 2022-01-18 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
US11969500B2 (en) 2017-10-06 2024-04-30 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
US12290595B2 (en) 2017-10-06 2025-05-06 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
US12364792B2 (en) 2018-01-08 2025-07-22 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
US12458589B2 (en) 2018-05-12 2025-11-04 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents
US12303619B2 (en) 2018-08-28 2025-05-20 Foundry Therapeutics, Inc. Polymer implants

Also Published As

Publication number Publication date
JP2024010067A (ja) 2024-01-23
JP2018511410A (ja) 2018-04-26
WO2016159885A1 (en) 2016-10-06
US20240226394A1 (en) 2024-07-11
EP4609886A2 (en) 2025-09-03
US12290616B2 (en) 2025-05-06
JP7714014B2 (ja) 2025-07-28
EP3586886A1 (en) 2020-01-01
EP4129350B1 (en) 2025-07-23
US20250222180A1 (en) 2025-07-10
JP7376520B2 (ja) 2023-11-08
EP4129350A1 (en) 2023-02-08
CN113181439A (zh) 2021-07-30
US20220072207A1 (en) 2022-03-10
US20190351108A1 (en) 2019-11-21
EP3277330A1 (en) 2018-02-07
EP3586886B1 (en) 2022-07-27
EP3277330A4 (en) 2018-11-14
EP4609886A3 (en) 2025-10-29
JP2021072894A (ja) 2021-05-13
JP6824188B2 (ja) 2021-02-03
JP2025160249A (ja) 2025-10-22
US11964076B2 (en) 2024-04-23
US20180193537A1 (en) 2018-07-12
CN107921180A (zh) 2018-04-17

Similar Documents

Publication Publication Date Title
GB201512030D0 (en) Composition
GB201506827D0 (en) Composition
GB201505527D0 (en) Composition
GB201521507D0 (en) Composition
SG11201705867VA (en) Composition
GB201506825D0 (en) Composition
GB201506830D0 (en) Composition
GB201506829D0 (en) Composition
PL3344702T3 (pl) Kompozycja
GB2545773B (en) Composition
GB201504665D0 (en) Composition
GB201522603D0 (en) Composition
GB201518348D0 (en) Composition
GB201515639D0 (en) Composition
GB201504307D0 (en) Composition
GB201522681D0 (en) Composition
GB201519327D0 (en) Composition
GB201514585D0 (en) Composition
GB201506828D0 (en) Composition
GB201505520D0 (en) Composition
GB2537648B (en) Composition
GB201511697D0 (en) Composition
GB201509044D0 (en) Composition
GB201508722D0 (en) Composition
GB201521384D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)